CJMB
Callan JMB Inc. Common StockCJMB
CJMB
About: Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.
Employees: 26
–
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for CJMB.
Financial journalist opinion
Neutral
GlobeNewsWire
5 days ago
Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs
Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries.
Neutral
GlobeNewsWire
1 month ago
Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update
Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option
Neutral
GlobeNewsWire
1 month ago
Callan JMB to Participate in Upcoming March Conferences
SPRING BRANCH, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following March 2025 investor conferences.
Neutral
GlobeNewsWire
2 months ago
Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations
SPRING BRANCH, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced a new comprehensive lease program for vaccine management that will enable government agencies and private organizations to provide crucial immunizations without the economic burden of purchasing the necessary equipment outright.
Neutral
GlobeNewsWire
2 months ago
Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering
SPRING BRANCH, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced that the underwriters of its previously announced initial public offering of shares of its common stock (“Common Stock”) have partially exercised their over-allotment option, resulting in the issuance of an additional 163,569 shares of Common Stock (the “Option Shares” or “Share”) at a public offering price of $4.00 per Share for additional gross proceeds of $654,276. After giving effect to the partial exercise of the over-allotment option, an aggregate of 1,443,569 shares of Common Stock have been issued in the initial public offering (the “Offering”) for aggregate net proceeds of approximately $4,729,319.78, after deducting underwriting discounts, commissions and offering expenses payable by the Company.
Neutral
GlobeNewsWire
2 months ago
Callan JMB Announces Closing of $5.12 Million Initial Public Offering
SPRING BRANCH, Texas, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced the closing of its previously announced initial public offering (the “Offering”) of 1,280,000 shares (the “Shares”) of common stock (“Common Stock”) at an initial public offering price of $4.00 per Share for a total of approximately $5,120,000 of gross proceeds to the Company before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. In addition, Callan has granted the underwriters a 45-day option to purchase, at the public offering price, up to an additional 192,000 shares of Common Stock at the public offering price, less the underwriting discounts and commissions.
Neutral
GlobeNewsWire
2 months ago
Callan JMB Announces Pricing of $5.12 Million Initial Public Offering
SPRING BRANCH, Texas, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced the pricing of its initial public offering (the “Offering”) of 1,280,000 shares (the “Shares”) of common stock (“Common Stock”) at an initial public offering price of $4.00 per Share for a total of approximately $5,120,000 of gross proceeds to the Company before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. In addition, Callan has granted the underwriters a 45-day option to purchase, at the public offering price, up to an additional 192,000 shares of Common Stock at the public offering price, less the underwriting discounts and commissions.
Charts implemented using Lightweight Charts™